Lewis H. Titterton jr - 29 Sep 2022 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Director
Signature
/s/ Lewis H. Titterton, Jr.
Issuer symbol
ANIX
Transactions as of
29 Sep 2022
Net transactions value
+$103,000
Form type
4
Filing time
30 Sep 2022, 10:34:25 UTC
Previous filing
16 Sep 2022
Next filing
04 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIX Common Stock Options Exercise $103,000 +40,000 +5.4% $2.58 774,070 29 Sep 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option Options Exercise $0 -40,000 -100% $0.000000* 0 29 Sep 2022 Common Stock 40,000 $2.58 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, pursuant to a stock option grant dated February 15, 2013.